Cargando…
Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?
OBJECTIVE: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP). MATERIALS AND METHODS: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women. Patients were c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651890/ https://www.ncbi.nlm.nih.gov/pubmed/29085705 http://dx.doi.org/10.4274/tjod.67674 |
_version_ | 1783272969671278592 |
---|---|
author | Yayla Abide, Çiğdem Vural, Fisun Kılıççı, Çetin Bostancı Ergen, Evrim Yenidede, İlter Eser, Ahmet Pekin, Oya |
author_facet | Yayla Abide, Çiğdem Vural, Fisun Kılıççı, Çetin Bostancı Ergen, Evrim Yenidede, İlter Eser, Ahmet Pekin, Oya |
author_sort | Yayla Abide, Çiğdem |
collection | PubMed |
description | OBJECTIVE: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP). MATERIALS AND METHODS: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women. Patients were categorized as mild ICP (<40 µmol/L) and severe ICP (≥40 µmol/L) with regard to serum bile acids. Inflammatory markers (neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV), and red blood cell distribution width (RDW) were compared between the groups. RESULTS: Patients with ICP had significantly decreased RDW and increased white blood cell counts (WBC), MPV and PLR, but no significant changes in NLR. The comparison of mild and severe cases with regard to NLR, PLR, WBC, and RDW was similar (p>0.05). MPV levels were significantly increased in severe group (p<0.05). CONCLUSION: WBC, MPV, and PLR were the inflammatory markers significantly increased, and RDW was signifantly reduced in ICP. MPV was the marker that significantly increased with the severity of disease. The use of inflammatory markers in the assessment of perinatal outcomes needs further studies. |
format | Online Article Text |
id | pubmed-5651890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-56518902017-10-30 Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? Yayla Abide, Çiğdem Vural, Fisun Kılıççı, Çetin Bostancı Ergen, Evrim Yenidede, İlter Eser, Ahmet Pekin, Oya Turk J Obstet Gynecol Clinical Investigation OBJECTIVE: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP). MATERIALS AND METHODS: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women. Patients were categorized as mild ICP (<40 µmol/L) and severe ICP (≥40 µmol/L) with regard to serum bile acids. Inflammatory markers (neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV), and red blood cell distribution width (RDW) were compared between the groups. RESULTS: Patients with ICP had significantly decreased RDW and increased white blood cell counts (WBC), MPV and PLR, but no significant changes in NLR. The comparison of mild and severe cases with regard to NLR, PLR, WBC, and RDW was similar (p>0.05). MPV levels were significantly increased in severe group (p<0.05). CONCLUSION: WBC, MPV, and PLR were the inflammatory markers significantly increased, and RDW was signifantly reduced in ICP. MPV was the marker that significantly increased with the severity of disease. The use of inflammatory markers in the assessment of perinatal outcomes needs further studies. Galenos Publishing 2017-09 2017-09-30 /pmc/articles/PMC5651890/ /pubmed/29085705 http://dx.doi.org/10.4274/tjod.67674 Text en ©Copyright 2017 by Turkish Society of Obstetrics and Gynecology Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigation Yayla Abide, Çiğdem Vural, Fisun Kılıççı, Çetin Bostancı Ergen, Evrim Yenidede, İlter Eser, Ahmet Pekin, Oya Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? |
title | Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? |
title_full | Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? |
title_fullStr | Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? |
title_full_unstemmed | Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? |
title_short | Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? |
title_sort | can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? |
topic | Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651890/ https://www.ncbi.nlm.nih.gov/pubmed/29085705 http://dx.doi.org/10.4274/tjod.67674 |
work_keys_str_mv | AT yaylaabidecigdem canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers AT vuralfisun canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers AT kılıccıcetin canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers AT bostancıergenevrim canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers AT yenidedeilter canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers AT eserahmet canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers AT pekinoya canwepredictseverityofintrahepaticcholestasisofpregnancyusinginflammatorymarkers |